ArticleLupus science & medicine2018
Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE.
Kerry A Casey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this paperpooled ittrialcites it